Target intelligence / Profile preview

Chicken anemia virus protein VP3 (Apoptin)

Target
Apoptin
Molecular classification
Other (viral protein), Transcription regulator (putative)
01

Overview

Chicken anemia virus protein VP3, commonly known as apoptin, is a 121-amino acid, proline-rich viral protein encoded by the chicken anemia virus (CAV)[1][2][3][4][5][7][10]. Apoptin has the unique property of inducing apoptosis selectively in transformed or malignant cells, but not in normal, untransformed cells[1][2][3][8]. In malignant cells, apoptin translocates to the nucleus through its distinct bipartite nuclear localization signals, multimerizes, and triggers programmed cell death, primarily via mitochondrial and caspase-3-dependent mechanisms and by interfering with DNA damage responses. It is being investigated as a tumor-specific therapeutic agent in cancer gene therapy, but has not been targeted by conventional small-molecule drugs or biologics[1][2][3][4][7][10]. Apoptin is highly specific to viral pathogenesis and is not part of the normal human proteome.

Other names
ApoptinVP3Chicken anemia virus apoptinCAV VP3
02

Mechanism of action

Induces apoptosis selectively in transformed and malignant cells via mitochondrial-mediated, caspase-dependent pathways and mitotic catastrophe. Translocates to the nucleus in cancer cells, where it aggregates and interferes with DNA damage repair, triggering cell death

03

Biological functions

ApoptosisCell deathRegulation of cell cycle (indirect, via apoptosis induction)
04

Disease associations

CancerInfection (specifically involved in the pathogenesis of chicken anemia virus)
05

Safety considerations

Selectivity for transformed/malignant cells limits toxicity to normal cells; however, as a viral protein, there could be immunogenicity or off-target effects in gene therapy settings

Beyond the preview

Go deeper on Chicken anemia virus protein VP3 (Apoptin).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chicken anemia virus protein VP3 (Apoptin).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call